The Cystic Fibrosis Foundation announced the recipients of its sixth annual Impact Grants.
Site Search
Marissa Benchea and Jeremy and Rachel Olimb to lead the Foundation’s volunteer advocacy base into a new chapter of CF
The Cystic Fibrosis Foundation awarded up to $4.7 million to EnBiotix Inc. to study the potential use of inhaled colistin as an additional option to treat Pseudomonas infections in people with cystic fibrosis who are not responding to current treatments.
The Cystic Fibrosis Foundation awarded up to $3.5 million to Arrevus Inc. to test a potential treatment for pulmonary exacerbations in people with cystic fibrosis in a late phase clinical trial.
This milestone was reached nearly two years ahead of the initiative’s five-year commitment. However, the Foundation aims to continue to support infection research at the same pace as it has in the past three years.
Addressing variability in newborn screening can prevent missed diagnoses and delays in early care intervention.
CEO pledge is part of the Foundation’s ongoing commitment to strengthen the organization and better serve all people with CF
Foundation welcomes new members to advance its mission
A transformative leader for more than two decades, Marshall will transition to advisory role